Surveillance for emerging threats to pregnant women and infants : data for action

V. Fan Tait(American Academy of Pediatrics), Susan Laird, John K. Iskander, Sharon Watkins(Pennsylvania Department of Health), Mahsa M. Yazdy, Phoebe Thorpe(Centers for Disease Control and Prevention), Ginny Bowen, Dana Meaney‐Delman(National Center for Emerging and Zoonotic Infectious Diseases)

Unknown

September 18, 2018

Cited by 0

Related Papers

Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy

|JAMA|2016|781

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020

|JAMA Internal Medicine|2020|747

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

|PubMed|2003|397

Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016

|MMWR Morbidity and Mortality Weekly Report|2017|299

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020

|MMWR Morbidity and Mortality Weekly Report|2020|276